| __timestamp | AstraZeneca PLC | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 9216000000 |
| Thursday, January 1, 2015 | 4646000000 | 8296000000 |
| Friday, January 1, 2016 | 4126000000 | 10044000000 |
| Sunday, January 1, 2017 | 4318000000 | 11560000000 |
| Monday, January 1, 2018 | 4936000000 | 10558000000 |
| Tuesday, January 1, 2019 | 4921000000 | 9351000000 |
| Wednesday, January 1, 2020 | 5299000000 | 8933000000 |
| Friday, January 1, 2021 | 12437000000 | 8284000000 |
| Saturday, January 1, 2022 | 12391000000 | 7952000000 |
| Sunday, January 1, 2023 | 8040000000 | 8200000000 |
| Monday, January 1, 2024 | 10207000000 | 8480000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. Over the past decade, AstraZeneca PLC and Teva Pharmaceutical Industries Limited have showcased contrasting trends in their cost of revenue. From 2014 to 2023, AstraZeneca's cost of revenue increased by approximately 38%, peaking in 2021 and 2022, while Teva's costs decreased by about 14% over the same period. This divergence highlights AstraZeneca's strategic investments in innovation and expansion, whereas Teva has focused on streamlining operations and cost-cutting measures. Notably, AstraZeneca's cost of revenue surged by 135% from 2020 to 2021, reflecting its aggressive growth strategy. Meanwhile, Teva's consistent reduction in costs underscores its commitment to efficiency. As the pharmaceutical landscape continues to shift, these companies' approaches to managing costs will be pivotal in determining their future market positions.
Cost Insights: Breaking Down AstraZeneca PLC and Bristol-Myers Squibb Company's Expenses
Cost of Revenue Comparison: AstraZeneca PLC vs GSK plc
Analyzing Cost of Revenue: AstraZeneca PLC and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for AstraZeneca PLC and Travere Therapeutics, Inc.
Cost Insights: Breaking Down AstraZeneca PLC and Evotec SE's Expenses
Cost Insights: Breaking Down AstraZeneca PLC and Xencor, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Mesoblast Limited